Loading...
Cart
0

In Vitro Fertilization Market in Asia Pacific - Country Analysis by End Users (Clinics, Hospitals, Surgical Centers, Clinical Research Institutes, Banks) Number of Cycles, Revenue, Market Share, Growth, Trends, and Forecast Through 2020

LI_14186
Pages: 105
Mar 2014 | 883 Views
 
Author(s) : Debbie Shields
Tables: 69
Charts: 15
 

The advancement of IVF market in Asia Pacific is characterized by major factors such as the rising standards of living and growing number of couples delaying parenthood due to professional and financial commitments. The Asia Pacific IVF market, valued at $1.3 billion in 2012, is estimated to reach $4.2 billion by 2020. As the chances of conceiving lowers with age, delayed pregnancy in women is one of the major driving factors of the IVF market. The success rate of getting pregnant with IVF technique is higher within the age group of 35-39. Other driving factors of the IVF market are rise in infertility rates due to rise in stress levels, change in life style and fertility related diseases.

Asia, in particular is facing the challenge of aging population and lower work force replacement. These trends would impact the socio-economic development and progress. Many countries in Asia Pacific region such as Japan, North and South Korea, China, Vietnam, Singapore and Thailand have fertility rates that are way below the replacement fertility levels. According to the East West center study, countries such as Japan, South Korea, Singapore, Taiwan, etc., Asia’s prosperous economies have the lowest birth rate worldwide.

Taiwan has the lowest birth per women which is 0.91 (2010) when compared with South Korea (1.15), Japan (1.39) and Singapore (1.16). This trend is due to couples postponing parenthood, couples preferring few children or rather no children at all.

Countries in Asia Pacific with such lower levels of fertility have initiated innovative assistance programs to promote parenthood and provide subsidies on fertility treatments such as IVF. In addition, lower treatment cost as compared to western countries has also proved to be positive for the artificial reproductive treatment (ART) industry in the region. With the advancing technologies, the success ratio of ART, especially IVF, has also grown in the region. Together, these factors have not only provided the region with an opportunity to improve on its birth rates, but also have added to the growth of the medical tourism industry in the region. Due to the rising trend in Medical tourism, many countries such as Malaysia, Thailand, Singapore, and India are gaining popularity.

In Vitro Fertilization Market in Asia Pacific-Another investing platform

KEY BENEFITS

  • In-depth analysis of the IVF market in 12 major country market with a cross sectional analysis of  end users segments
  • Quantitative analysis of the current market and estimations through 2013-2020
  • Assessment and ranking of the factors affecting the global market and impact analysis of the same
  • Analysis of trends in various geographic segments that would help the companies to plan their strategies depending on the region

COVERAGE

For the purpose of better understanding of the market, the report has covered 12 country markets and has presented a cross sectional analysis of each country market for end user segments. Both revenue and number of IVF cycles performed at various end use segments is calculated based on various indicators, authentic secondary sources, government publications and primary research with leading IVF providers in each of the country. The qualitative analysis is carried out for each country market for major trends and market dynamics. The major countries covered in this study include:

  • India
  • China
  • Japan
  • Vietnam
  • Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Indonesia
  • Philippines
  • Singapore

Each of these country markets has been analyzed for following end user segments:

  • Hospitals
  • Clinics
  • Surgical Centers
  • Research institutes
  • Banks

Apart from that, profiles of major market player in each of the country have also been provided for better understanding of market strategy and competitive scenario.

 

  1. REPORT OUTLINE

1.1. Report Description
1.2. Key Benefits
1.3. Coverage
1.4. Research Methodology

1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Models

2. EXECUTIVE SUMMARY

3. ASIA PACIFIC IN VITRO FERTILIZATION (IVF) MARKET (REVENUE AND NUMBER OF CYCLES)

 3.1. Overview
 3.2. IVF Pricing Trends by Country
 3.3. IVF Cycles by Country
 3.4. Drivers
 3.5. Restraints
 3.6. Opportunities

 3.7. Market by End User

3.7.1. Fertility clinics
3.7.2. Hospitals
3.7.3. Surgical centers
3.7.4. Banks
3.7.5. Clinical research institutes

3.8. Profiles of Major Players

3.8.1. Thermo Fisher Scientific Inc.

3.8.1.1. Company overview
3.8.1.2. Company snapshot
3.8.1.3. Financial overview
3.8.1.4. Market share
3.8.1.5. Strategic moves and developments

3.8.2. EMD Serono, Inc.

3.8.2.1. Company overview
3.8.2.2. Company snapshot
3.8.2.3. Financial overview
3.8.2.4. Market share
3.8.2.5. Strategic moves and developments

3.8.3. Sun Pharmaceutical

3.8.3.1. Company overview
3.8.3.2. Company snapshot
3.8.3.3. Financial overview
3.8.3.4. Market share
3.8.3.5. Strategic moves and developments

3.8.4. Cadila Healthcare Ltd.

3.8.4.1. Company overview
3.8.4.2. Company snapshot
3.8.4.3. Financial overview
3.8.4.4. Market share
3.8.4.5. Strategic moves and developments

3.8.5. LG Life Sciences.

 3.8.5.1. Company overview
3.8.5.2. Company snapshot
3.8.5.3. Financial overview
3.8.5.4. Market share
3.8.5.5. Strategic moves and developments

4. CHINA IVF MARKET (REVENUE AND NUMBER OF CYCLES)

4.1. Number of Cycles by Hospitals/Clinics

4.2. Market by End User

4.2.1. Fertility clinics
4.2.2. Hospitals
4.2.3. Surgical centers
4.2.4. Banks
4.2.5. Clinical research institutes

4.3. Drivers
4.4. Restraints
4.5. Regulatory issues, legislations and authorities
4.6. Insurance reimbursement scenario
4.7. Profiles of Major Players (Reproductive & and genetic Hospital Citic-Xiangya, Shenyang Hospital, China, IVF Center China, Shandong Provincial Hospital, China, Centre for Reproductive Medicine China)

4.7.1. Company overview
4.7.2. Company snapshot
4.7.3. Financial overview
4.7.4. Market share
4.7.5. Strategic moves and developments

5. JAPAN IVF MARKET (REVENUE AND NUMBER OF CYCLES)

5.1. Number of Cycles by Hospitals/Clinics
5.2. Market by End User

5.2.1. Fertility clinics
5.2.2. Hospitals
5.2.3. Surgical centers
5.2.4. Banks
5.2.5. Clinical research institutes

5.3. Drivers
5.4. Restraints
5.5. Regulatory issues, legislations and authorities
5.6. Insurance reimbursement scenario
5.7. Profiles of Major Players (Hiroshima Hart Clinic, IVF Japan, The Advanced Reproductive Technological Institute (ARMT), Yoshida Ladies Clinic Reproductive ART Center, Iwaki-Women's Clinic)

5.7.1. Company overview
5.7.2. Company snapshot
5.7.3. Financial overview
5.7.4. Market share
5.7.5. Strategic moves and developments

6. KOREA IVF MARKET (REVENUE AND NUMBER OF CYCLES)

6.1. Number of Cycles by Hospitals/Clinics
6.2. Market by End User

6.2.1. Fertility clinics
6.2.2. Hospitals
6.2.3. Surgical centers
6.2.4. Banks
6.2.5. Clinical research institutes

6.3. Regulatory issues, legislations and authorities
6.4. Insurance reimbursement scenario
6.5. Profiles of Major Players (Maria Fertility Hospital, Cha General Hospital, Seoul National University Hospital IVF Center, Dongtan Cheil Women's Clinic Ajou University)

6.5.1. Company overview
6.5.2. Company snapshot
6.5.3. Financial overview
6.5.4. Market share
6.5.5. Strategic moves and developments

7. INDIA IVF MARKET (REVENUE AND NUMBER OF CYCLES)

7.1. Number of Cycles by Hospitals/Clinics
7.2. Market by End User

7.2.1. Fertility clinics
7.2.2. Hospitals
7.2.3. Surgical centers
7.2.4. Banks
7.2.5. Clinical research institutes

7.3. Regulatory issues, legislations and authorities
7.4. Insurance reimbursement scenario
7.5. Profiles of Major Players (Bourn Hall Clinic, Southend Fertility and IVF Centre, Morpheus IVF Fertility Center, Bloom Fertility Center, Manipal Ankur, Cloudnine Fertility, Nova IVI Fertility)

7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Financial overview
7.5.4. Market share
7.5.5. Strategic moves and developments

8. AUSTRALIA IVF MARKET (REVENUE AND NUMBER OF CYCLES)

8.1. Number of Cycles by Hospitals/Clinics
8.2. Market by End User

8.2.1. Fertility clinics
8.2.2. Hospitals
8.2.3. Surgical centers
8.2.4. Banks
8.2.5. Clinical research institutes

8.3. Regulatory issues, legislations and authorities
8.4. Insurance reimbursement scenario
8.5. Profiles of Major Players (Virtus Health, Monash IVF, Genea Limited, City Fertility, Flindersfertility)

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Financial overview
8.5.4. Market share
8.5.5. Strategic moves and developments

9. NEW ZEALAND IVF MARKET (REVENUE AND NUMBER OF CYCLES)

9.1. Number of Cycles by Hospitals/Clinics
9.2. Market by End User

9.2.1. Fertility clinics
9.2.2. Hospitals
9.2.3. Surgical centers
9.2.4. Banks
9.2.5. Clinical research institutes

9.3. Regulatory issues, legislations and authorities
9.4. Insurance reimbursement scenario
9.5. Profiles of Major Players (Fertility Associates New Zealand, Fertility Plus, Repromed)

9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Financial overview
9.5.4. Market share
9.5.5. Strategic moves and developments

10. SOUTH-EAST ASIA IVF MARKET (REVENUE AND NUMBER OF CYCLES)

10.1. Number of Cycles by Hospitals/Clinics
10.2. Market by End User

10.2.1. Fertility clinics
10.2.2. Hospitals
10.2.3. Surgical centers
10.2.4. Banks
10.2.5. Clinical research institutes

10.3. Regulatory issues, legislations and authorities
10.4. Insurance reimbursement scenario

 10.5. SINGAPORE IVF MARKET (REVENUE AND NUMBER OF CYCLES)

10.5.1. Number of Cycles by Hospitals/Clinics
10.5.2. Market by End User

10.5.2.1. Fertility clinics
10.5.2.2. Hospitals
10.5.2.3. Surgical centers
10.5.2.4. Banks
 10.5.2.5. Clinical research institutes

10.5.3. Regulatory issues, legislations and authorities
10.5.4. Insurance reimbursement scenario
10.5.5. Profiles of Major Players (NUH IVF Centre, Thomson Fertility Centre, Mount Elizabeth Fertility Center, Parkview Fertility Centre, Raffles Fertility Centre)

10.5.5.1. Company overview
10.5.5.2. Company snapshot
10.5.5.3. Financial overview
10.5.5.4. Market share
10.5.5.5. Strategic moves and developments

 10.6. MALAYSIA IVF MARKET (REVENUE AND NUMBER OF CYCLES)

10.6.1. Number of Cycles by Hospitals/Clinics
10.6.2. Market by End User

10.6.2.1. Fertility clinics
10.6.2.2. Hospitals
10.6.2.3. Surgical centers
10.6.2.4. Banks
10.6.2.5. Clinical research institutes

10.6.3. Regulatory issues, legislations and authorities
10.6.4. Insurance reimbursement scenario
10.6.5. Profiles of Major Players (Subang Fertility Center Subang Jaya Hospital, TMC Fertility Center formerly known as Damansara Fertility center, Fertility Centre Scaudinavia, Concept Fertility Center (Malaysia), Medically Assisted Conception Centre)

10.6.5.1. Company overview
10.6.5.2. Company snapshot
10.6.5.3. Financial overview
10.6.5.4. Market share
10.6.5.5. Strategic moves and developments

 10.7. INDONESIA IVF MARKET (REVENUE AND NUMBER OF CYCLES)

10.7.1. Number of Cycles by Hospitals/Clinics
10.7.2. Market by End User

10.7.2.1. Fertility clinics
10.7.2.2. Hospitals
10.7.2.3. Surgical centers
10.7.2.4. Banks
10.7.2.5. Clinical research institutes

10.7.3. Regulatory issues, legislations and authorities
10.7.4. Insurance reimbursement scenario
10.7.5. Profiles of Major Players (Anugerah Fertility Center, Morula IVF, Fertility Centre, Siloam Hospitals Surabana, Aster Fertility Clinic, Yasmin IVF)

10.7.5.1. Company overview
10.7.5.2. Company snapshot
10.7.5.3. Financial overview
10.7.5.4. Market share
10.7.5.5. Strategic moves and developments

 10.8. PHILIPPINES IVF MARKET (REVENUE AND NUMBER OF CYCLES)

10.8.1. Number of Cycles by Hospitals/Clinics
10.8.2. Market by End User

10.8.2.1. Fertility clinics
10.8.2.2. Hospitals
10.8.2.3. Surgical centers
10.8.2.4. Banks
10.8.2.5. Clinical research institutes

10.8.3. Regulatory issues, legislations and authorities
10.8.4. Insurance reimbursement scenario
10.8.5. Profiles of Major Players (Center for Reproductive Medicine, Victory Art Lab, CRM-MIA-Philippines)

10.8.5.1. Company overview
10.8.5.2. Company snapshot
10.8.5.3. Financial overview
10.8.5.4. Market share
10.8.5.5. Strategic moves and developments

 10.9. THAILAND IVF MARKET (REVENUE AND NUMBER OF CYCLES)

10.9.1. Number of Cycles by Hospitals/Clinics
10.9.2. Market by End User

10.9.2.1. Fertility clinics
10.9.2.2. Hospitals
10.9.2.3. Surgical centers
10.9.2.4. Banks
10.9.2.5. Clinical research institutes

10.9.3. Regulatory issues, legislations and authorities
10.9.4. Insurance reimbursement scenario
10.9.5. Profiles of Major Players (Bangkok Fertility Center, Jetanin Institute for Assisted Reproduction, Perfect Woman Institute Piyavate Hospital, Ramathibodi Hosp, Mahidol University, Bangkok Thailand, Siriraj Hospital)

10.9.5.1. Company overview
10.9.5.2. Company snapshot
10.9.5.3. Financial overview
10.9.5.4. Market share
10.9.5.5. Strategic moves and developments

 10.10. VIETNAM IVF MARKET (REVENUE AND NUMBER OF CYCLES)

10.10.1. Number of Cycles by Hospitals/Clinics
10.10.2. Market by End User

10.10.2.1. Fertility clinics
10.10.2.2. Hospitals
10.10.2.3. Surgical centers
10.10.2.4. Banks
10.10.2.5. Clinical research institutes

10.10.3. Regulatory issues, legislations and authorities
10.10.4. Insurance reimbursement scenario
10.10.5. Profiles of Major Players (IVF Center of National Hospital of GB. Gyn, IVF Lab Tu Du Hospital Vietnam, IVF Van Hanh, IVFAS, Tu Du - Ho Chi Minh City Vietnam)

10.10.5.1. Company overview
10.10.5.2. Company snapshot
10.10.5.3. Financial overview
10.10.5.4. Market share
10.10.5.5. Strategic moves and developments

 

LIST OF TABLES
TABLE 1    ASIA PACIFIC IVF CYCLES BY COUNTRY, 2012 – 2020 (THOUSAND)
TABLE 2    ASIA PACIFIC IVF REVENUE BY COUNTRY, 2012 – 2020 ($MILLION)
TABLE 3    ASIA PACIFIC IVF CYCLES BY END USER, 2012 – 2020 (THOUSAND)
TABLE 4    ASIA PACIFIC IVF REVENUE BY END USER, 2012 – 2020 ($MILLION)
TABLE 5    THERMO FISHER SCIENTIFIC INC  BUSINESS OVERVIEW
TABLE 6    COMPANY SNAPSHOT
TABLE 7    EMD SERONO INC BUSINESS OVERVIEW
TABLE 8    COMPANY SNAPSHOT
TABLE 9    SUN PHARMACEUTICAL BUSINESS OVERVIEW
TABLE 10  COMPANY SNAPSHOT
TABLE 11  CADILA HEALTH CARE BUSINESS OVERVIEW
TABLE 12  COMPANY SNAPSHOT
TABLE 13  LG LIFE SCIENCE  BUSINESS OVERVIEW
TABLE 14  COMPANY SNAPSHOT
TABLE 15  CHINA IVF REVENUE BY END USERS, 2012 – 2020 ($MILLION)
TABLE 16  CHINA IVF CYCLES BY END USERS, 2012 – 2020 (THOUSAND)
TABLE 17  COOK MEDICAL INC BUSINESS OVERVIEW
TABLE 18  COMPANY SNAPSHOT
TABLE 19  VETROLIFE AB INC BUSINESS OVERVIEW
TABLE 20  COMPANY SNAPSHOT
TABLE 21  INDIA IVF REVENUE BY END USERS, 2012 – 2020 ($MILLION)
TABLE 22  INDIA IVF CYCLES BY END USERS, 2012 – 2020 (THOUSAND)
TABLE 23  SUN PHARMACEUTICAL BUSINESS OVERVIEW
TABLE 24  COMPANY SNAPSHOT
TABLE 25  TRIVECTOR ORIGIO SCIENTIFIC  BUSINESS OVERVIEW
TABLE 26  COMPANY SNAPSHOT
TABLE 27  LAB IVF ASIA BUSINESS OVERVIEW
TABLE 28  COMPANY SNAPSHOT
TABLE 29  LG LIFE SCIENCE  BUSINESS OVERVIEW
TABLE 30  COMPANY SNAPSHOT
TABLE 31  CADILA HEALTH CARE  BUSINESS OVERVIEW
TABLE 32  COMPANY SNAPSHOT
TABLE 33  KOREA IVF REVENUE BY END USERS, 2012 – 2020 ($MILLION)
TABLE 34  KOREA IVF CYCLES BY END USERS, 2012 – 2020 (THOUSAND)
TABLE 35  NEW ZEALAND IVF REVENUE BY END USERS, 2012 – 2020 ($MILLION)
TABLE 36  NEW ZEALAND IVF CYCLES BY END USERS, 2012 – 2020 (THOUSAND)
TABLE 37  AUSTRALIA IVF REVENUE BY END USERS, 2012 – 2020 ($MILLION)
TABLE 38  AUSTRALIA IVF CYCLES BY END USERS, 2012 – 2020 (THOUSAND)
TABLE 39  GENEA BIOMEDX TECHNOLOGIES BUSINESS OVERVIEW
TABLE 40  COMPANY SNAPSHOT
TABLE 41  THERMO FISHER SCIENTIFIC INC  BUSINESS OVERVIEW
TABLE 42  COMPANY SNAPSHOT
TABLE 43  JAPAN IVF REVENUE BY END USERS, 2012 – 2020 ($MILLION)
TABLE 44  JAPAN IVF CYCLES BY END USERS, 2012 – 2020 (THOUSAND)
TABLE 45  EMD SERONO INC BUSINESS OVERVIEW
TABLE 46  COMPANY SNAPSHOT
TABLE 47  BIRTH RATE OF SOUTH-EAST ASIA PER THOUSAND, 2012
TABLE 48  SOUTH-EAST ASIA IVF REVENUE BY END USERS, 2012 – 2013 ($MILLION)
TABLE 49  SOUTH-EAST ASIA IVF REVENUE BY COUNTRY, 2012 – 2013 ($MILLION)
TABLE 50  SOUTH-EAST ASIA IVF CYCLES BY COUNTRY, 2012 – 2013 (THOUSAND)
TABLE 51  SOUTH-EAST ASIA IVF CYCLES BY END USER, 2012 – 2013 (THOUSAND)
TABLE 52  SINGAPORE IVF REVENUE BY END USERS, 2012 – 2020 ($MILLION)
TABLE 53  SINGAPORE IVF CYCLES BY END USERS, 2012 – 2020 (THOUSAND)
TABLE 54  PACIFIC HEALTHCARE  BUSINESS OVERVIEW
TABLE 55  COMPANY SNAPSHOT
TABLE 56  ESCO TECHNOLOGIES  BUSINESS OVERVIEW
TABLE 57  COMPANY SNAPSHOT
TABLE 58  EMD SERONO INC BUSINESS OVERVIEW
TABLE 59  COMPANY SNAPSHOT
TABLE 60  MALAYSIA IVF REVENUE BY END USERS, 2012 – 2020 ($MILLION)
TABLE 61  MALAYSIA IVF CYCLES BY END USERS, 2012 – 2020 (THOUSAND)
TABLE 62  INDONESIA IVF REVENUE BY END USERS, 2012 – 2020 ($MILLION)
TABLE 63  INDONESIA IVF CYCLES BY END USERS, 2012 – 2020 (THOUSAND)
TABLE 64  PHILIPPINES IVF REVENUE BY END USERS, 2012 – 2020 ($MILLION)
TABLE 65  PHILIPPINES IVF CYCLES BY END USERS, 2012 – 2020 (THOUSAND)
TABLE 66  THAILAND IVF REVENUE BY END USERS, 2012 – 2020 ($MILLION)
TABLE 67  THAILAND IVF CYCLES BY END USERS, 2012 – 2020 (THOUSAND)
TABLE 68  VIETNAM IVF REVENUE BY END USERS, 2012 – 2020 ($MILLION)
TABLE 69  VIETNAM IVF CYCLES BY END USERS, 2012 – 2020 (THOUSAND)

 


LIST OF FIGURES

FIG. 1   ASIA PACIFIC IVF MARKET BY COUNTRY, 2013 & 2020 ($MILLION)
FIG. 2   ASIA PACIFIC IVF MARKET BY END USERS, 2012 – 2020 ($MILLION)
FIG. 3  PERCENTAGE OF PEOPLE WHO PERCEIVED VARIOUS INFERTILITY REASONS (SINGAPORE, THAILAND, INDONESIA AND CHINA)
FIG. 4   CHINA FERTILITY RATE (CHILDREN BORN/WOMEN)
FIG. 5   TOTAL FERTILITY RATE (CHILDREN BORN/ WOMEN)
FIG. 6   TOTAL FERTILITY RATE (CHILDREN BORN/WOMEN) - SOUTH KOREA
FIG. 7   TOTAL FERTILITY RATE (CHILDREN BORN/ WOMEN)
FIG. 8   TOTAL FERTILITY RATE (CHILDREN BORN/ WOMEN)
FIG. 9   TOTAL FERTILITY RATE (CHILDREN BORN/ WOMEN)
FIG. 10  SINGAPORE FERTILITY RATE CHILD BORN/WOMEN
FIG. 11  MALAYSIA FERTILITY RATE CHILD BORN/WOMEN
FIG. 12  INDONESIA FERTILITY RATE CHILD BORN/WOMEN
FIG. 13  PHILIPPINES FERTILITY RATE CHILD BORN/WOMEN
FIG. 14  THAILAND FERTILITY RATE CHILD BORN/WOMEN
FIG. 15  VIETNAM FERTILITY RATE CHILD BORN/WOMEN

  

 
 

Countries in Asia Pacific with such lower levels of fertility have initiated innovative assistance programs to promote parenthood and provide subsidies on fertility treatments such as IVF. In addition, lower treatment cost as compared to western countries has also proved to be encouraging for the artificial reproductive treatment (ART) industry in the region.

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Download Sample

Request Customization

 

Download Sample

OR

Purchase Full Report of
In Vitro Fertilization Market

  • Online Only
  • $3629
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $4032
  • Restricted to one authorized user
  • One print only
  • Available in Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5639
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6773
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $9445
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 
Download Sample

Buy Full Version
"In Vitro Fertilization Market"
Purchase Enquiry